SSEA-4 Antibody, anti-human, REAlease®
RECOMBINANT
Clone:
REAL232
Type of antibody:
Releasable antibodies, Primary antibodies, Recombinant antibodies
Applications:
FC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for SSEA-4 Antibody, anti-human, REAlease®

Flow cytometry applications
FITC
VioBlue
VioGreen
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Conjugate:
FITC
Used products:
130-115-940, 130-122-618, 130-115-870
Description:
A mixture of NTERA-2 and U937 cells was stained with REAlease Anti-SSEA-4-FITC (B) or with the corresponding REAL Control (A). REAlease Anti-SSEA-4-FITC was released using the REAlease Release Reagent (C). To show epitope accessibility after REAlease Complex release, the cells were washed with the REAlease Stop Reagent and restained with REAlease Anti-SSEA-4-FITC (D). Cells were analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI).

Application imageView details view details

Application imageView details view details

Application imageView details view details

Application imageView details view details
Specifications for SSEA-4 Antibody, anti-human, REAlease®
Overview

Clone REAL232 is an antibody fragment derived from the full SSEA-4 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAlease Complex to bind markers with high avidity.

Clone REAL232 recognizes the glycolipid carbohydrate epitope stage specific embryonic antigen 4 (SSEA-4). SSEA-4 is found on undifferentiated human embryonic stem (ES) cells, induced pluripotent (iPS) cells, embryonal carcinoma (EC) cells, and embryonic germ (EG) cells as well as a variety of somatic stem cells, such as dental pulp stem cells, umbilical cord blood-derived very small embryonic like stem cells (VSELs), and mesenchymal stromal cells.

The REAlease Kits consist of the respective fluorochrome-conjugated REAlease Complexes and the REAlease Support Kit for removal of the REAlease Complexes and optional relabeling with different fluorochrome-conjugated REAlease Complexes.

Detailed product information

Technical specifications

Clone
REAL232
Clonality
monoclonal
Isotype control
Control Antibody
Host
cell line
Type of antibody
Releasable antibodies, Primary antibodies, Recombinant antibodies
Species reactivity
human
Cross-reactivity
rabbit, mouse, canine, chicken
Antigen
SSEA-4
Distribution of antigen
ES and iPS cells, embryonic germ cells
RRID
AB_2857555, AB_2784463, AB_2751282, AB_2784462, AB_2751290, AB_2751278, AB_2751286
Resources for SSEA-4 Antibody, anti-human, REAlease®
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for SSEA-4 Antibody, anti-human, REAlease®
Publications
  1. Kannagi, R. et al. (1983) Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside. EMBO J. 2 (12): 2355-2361
  2. Gang, E. J. et al. (2007) SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109 (4): 1743-1751
  3. Truong, T. T. et al. (2011) SSEA4 is a potential negative marker for the enrichment of human corneal epithelial stem/progenitor cells. Invest. Ophthalmol. Vis. Sci. 52 (9): 6315-6320

You have previously chosen International as your location.
What do you want to do?